Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Key to changes
?
Text removedfrom 2019 Q1- Text added to 2019 Q2
Content analysis
?Positive | |
Negative | |
Uncertain | |
Constraining | |
Legalese | |
Litigous | |
Readability |
H.S. sophomore Avg
|
Content analysis
?Positive | |
Negative | |
Uncertain | |
Constraining | |
Legalese | |
Litigous | |
Readability |
H.S. sophomore Avg
|
New words:
Acer, adrenocortical, affiliated, automatically, Basel, carcinoma, card, Carole, codified, collateralize, deposit, difficulty, dual, elevated, ESPP, Fast, fezolinetant, holder, hot, insolvency, irrevocably, juvenile, KaNDy, KNDy, landlord, lesser, liver, menopausal, moot, neurokinin, night, Nuechterlein, osenetant, overactive, owner, pediatric, play, preceding, receptor, resumed, Roche, role, Ryan, Sojournix, step, sublicensable, successor, vasomotor, VMS, Zeidan
Removed:
purpose, revalued
Valuein 2019 Q1 filing- Value in 2019 Q2 filing
Original filings
Filing view